A Study to Decrease Suicidal Thinking Using Ketamine

NCT02418702 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped PI no longer at facility.

Conditions

Depression
Suicide

Interventions

DRUG: 0.2 mg/kg ketamine
OTHER: placebo

Sponsor

United States Naval Medical Center, San Diego